Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Antimicrobial Proteins01:23

Antimicrobial Proteins

881
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
881
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.7K
Antibiotic Selection00:57

Antibiotic Selection

52.2K
Overview
52.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Machine Learning Model for the Proteome-Wide Prediction of Lipid-Interacting Proteins.

Journal of chemical information and modeling·2025
Same author

Activation and Allostery in a Fungal SAMHD1 Hydrolase: An Evolutionary Blueprint for dNTP Catabolism.

JACS Au·2025
Same author

Engineering Cell-Specific Protein Delivery Vehicles for Erythroid Lineage Cells.

ACS bio & med chem Au·2025
Same author

Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics.

Chemical reviews·2025
Same author

Lipid Trafficking in Diverse Bacteria.

Accounts of chemical research·2024
Same author

Novel sterol binding domains in bacteria.

eLife·2024

Related Experiment Video

Updated: May 30, 2025

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

10.2K

Identifying Opportunity Targets in Gram-Negative Pathogens for Infectious Disease Mitigation.

Isaac A Paddy1,2, Laura M K Dassama2,3,4

  • 1Department of Chemical and Systems Biology, Stanford School of Medicine, Stanford, California 94305-6104, United States.

ACS Central Science
|January 27, 2025
PubMed
Summary

Antimicrobial drug resistance (AMR) is a major global health threat. This study identifies vulnerabilities in Gram-negative pathogens as potential targets for developing new antibiotics to combat AMR.

More Related Videos

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
09:09

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

7.8K
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.1K

Related Experiment Videos

Last Updated: May 30, 2025

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

10.2K
High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
09:09

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

7.8K
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.1K

Area of Science:

  • Microbiology
  • Chemical Biology
  • Infectious Diseases

Background:

  • Antimicrobial drug resistance (AMR) poses a significant global health challenge, exacerbated by climate change, rising nosocomial infections, and a lack of new antibiotic discovery.
  • Addressing AMR requires a multidisciplinary approach, with chemical microbiologists playing a key role in understanding and mitigating the problem.

Purpose of the Study:

  • To identify and explore vulnerabilities in human pathogens, particularly Gram-negative bacteria, as potential targets for novel antibiotic development.
  • To highlight specific protein targets within Gram-negative organisms that could be modulated by small molecules to combat infectious diseases.

Main Methods:

  • Focus on identifying "opportunity targets" within human pathogens, specifically proteins in Gram-negative bacteria.
  • Analysis of pathogen vulnerabilities, considering the challenges posed by the outer membrane barrier of Gram-negative organisms.

Main Results:

  • Gram-negative pathogens present unique challenges due to their external membrane, making them recalcitrant to many existing antibiotics.
  • Specific protein targets within these pathogens have been identified as potential "druggable" sites.

Conclusions:

  • Exploiting pathogen vulnerabilities, particularly in Gram-negative bacteria, offers a promising avenue for developing new classes of antibiotics.
  • Targeting these identified proteins could lead to novel therapeutic strategies for infectious disease mitigation and help alleviate current AMR concerns.